Issue 10/2013
Content (7 Articles)
Drug–Drug Interactions Between HMG-CoA Reductase Inhibitors (Statins) and Antiviral Protease Inhibitors
Benoit Chauvin, Sylvain Drouot, Aurélie Barrail-Tran, Anne-Marie Taburet
The Role of Pharmacogenetics in Drug Disposition and Response of Oral Glucose-Lowering Drugs
N. van Leeuwen, J. J. Swen, H.-J. Guchelaar, L. M. ’t Hart
Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
Lei Diao, Bernd Meibohm
Antimicrobial Treatment of Febrile Neutropenia: Pharmacokinetic–Pharmacodynamic Considerations
Tiphaine Goulenok, Bruno Fantin
The Relationship Between Fluticasone Furoate Systemic Exposure and Cortisol Suppression
Ann Allen
Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide
Willi Cawello, Uwe Fuhr, Ursula Hering, Haidar Maatouk, Atef Halabi
Population Pharmacokinetic Analysis for Hydrocodone Following the Administration of Hydrocodone Bitartrate Extended-Release Capsules
Murad R. Melhem, Christopher M. Rubino, Stephen J. Farr, Cynthia Y. Robinson